Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aytu Biopharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.575 Good day, everyone, and welcome to the A2 Biopharma Fiscal 2025 Q2 00:00:04.575 -- 00:00:10.081 Earnings Call. At this time, all participants have been placed on a listen-only mode. 00:00:10.081 -- 00:00:14.725 If you have any questions or comments during the presentation, you may press star 1 on 00:00:14.725 -- 00:00:18.409 your phone to enter the question queue at any time, and we will open the floor for your 00:00:18.409 -- 00:00:20.491 questions and comments after the presentation. 00:00:20.491 -- 00:00:25.396 It is now my pleasure to turn the floor over to your host, Robert Bloom. 00:00:25.396 -- 00:00:27.301 Sir, the floor is yours. 00:00:27.301 -- 00:00:31.509 All right, thank you very much and good afternoon everyone, as the operator indicated 00:00:31.509 -- 00:00:36.918 during today's call we will be discussing a to bio pharma fiscal 2025 second 00:00:36.918 -- 00:00:43.226 quarter operational and financial results for the period ended December 31 2024. 00:00:43.931 -- 00:00:49.060 Joining us on today's call is a to chief executive officer josh disbro and Ryan 00:00:49.060 -- 00:00:52.394 sell horn the company's chief financial officer. 00:00:52.394 -- 00:00:56.560 At the conclusion of today's prepared remarks, we will open the call for a question and 00:00:56.560 -- 00:01:00.386 answer session. I'd like to remind everyone that today's call is being recorded. 00:01:00.386 -- 00:01:05.334 A replay of today's call will be available by using the teleconference numbers and conference 00:01:05.334 -- 00:01:10.342 ID provided in the press release issued earlier today or by utilizing the 00:01:10.342 -- 00:01:14.728 link on the company's website under events and presentations. 00:01:14.728 -- 00:01:18.614 Finally, I'd also like ...